Financials

  • Market Capitalization 1.78 B
  • Employee 167
  • Founded 2019
  • CEO N/A
  • Website www.zenasbio.com
  • Headquarter Delaware, United States
  • FIGI BBG01J1MG9D6
  • Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-2.15
売上高対価格比率

Related tickers

#名前価格24時間%7日%1か月%1年%時価総額過去7日
2076
RXRX
Recursion Pharmaceuticals, Inc. - Class A Common Stock
3.38 USD+1.20%-7.40%+3.36%-36.11%1.79 B USD
2077
PGEN
Precigen, Inc. - Common Stock
5.11 USD-0.20%-6.75%+6.24%+174.73%1.82 B USD
2117
IMCR
Immunocore Holdings plc - American Depositary Shares
33.60 USD+0.39%+1.94%+17.44%+0.36%1.71 B USD
2120
MRVI
Maravai LifeSciences Holdings, Inc. - Class A common stock
6.75 USD+3.69%+18.42%+36.09%+158.62%1.74 B USD